The Food And Drug Administration has approved a new weight loss device that is implanted into the body, according to the Los Angeles Times.
The device, called the Maestro Rechargeable System, is for obese adults that "have a BMI between 35 and 45, who have at least one other obesity-related illness".
The Maestro System is the first weight loss device to be approved since 2007. Enteromedics, the company that manufactures the device, has developed a technology it calls VBLOC, or "vagal blocking therapy." The Maestro System delivers VBLOC Therapy through electrodes "that are placed in contact with the trunks of the vagus nerves just above the junction between the esophagus and the stomach."
That sounds like a lot. Let me break down for you some of the science talk:
Basically, the device is implanted just above the stomach area in order to interfere with your body's ability to send messages to the brain when it's hungry. The result is that people tend to feel less hungry and eat less. The hope is that this will lead to sustained weight loss.
According to Enteromedics, over 600 patients have already been implanted with the Maestro System. With regards to safety, the device can be inactivated or completely removed at the patient's desire.
The cost of the device has not been set, but it's estimated that the price will be set for "somewhere between $20,000 and $30,000."
What do you think about the new device? Let us know in the comments.